Cargando…
Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis
BACKGROUND: A substantial number of patients clinically diagnosed with Alzheimer’s disease do not harbor amyloid pathology. We analyzed the presence and extent of tau deposition and neurodegeneration in amyloid-positive (AD) and amyloid-negative (nonAD) ADNI subjects while also taking into account a...
Autores principales: | Stage, Eddie C., Svaldi, Diana, Phillips, Meredith, Canela, Victor Hugo, Duran, Tugce, Goukasian, Naira, Risacher, Shannon L., Saykin, Andrew J., Apostolova, Liana G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409508/ https://www.ncbi.nlm.nih.gov/pubmed/32758274 http://dx.doi.org/10.1186/s13195-020-00647-w |
Ejemplares similares
-
The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism
por: Stage, Eddie, et al.
Publicado: (2016) -
Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative
por: Stage, Eddie, et al.
Publicado: (2021) -
Association of the top 20 Alzheimer's disease risk genes with [(18)F]flortaucipir PET
por: Stage, Eddie, et al.
Publicado: (2022) -
Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study
por: Goukasian, Naira, et al.
Publicado: (2019) -
Optimizing differential identifiability improves connectome predictive modeling of cognitive deficits from functional connectivity in Alzheimer's disease
por: Svaldi, Diana O., et al.
Publicado: (2021)